Novelix Pharmaceuticals Ltd

Novelix Pharma Allots 400K Shares to Strategic Investors 💼📈

- 400,000 equity shares allotted at ₹20 each (₹10 face value + ₹10 premium).

- Warrants converted from a preferential issue approved by shareholders on November 18, 2024.

- Total funds received: ₹60,00,000 (75% of issue price) for 400K warrants out of 15M originally allotted.

- Non-promoter investors: Arpan Vipin Mantri (200K shares), Yellaboina Dhanraj (150K shares), Sudhir Kumar Agarwal (50K shares).

- Paid-up equity capital increased from ₹172.15M (17.215M shares) to ₹176.15M (17.615M shares).

- Allotment approved on January 19, 2026, at Hyderabad office.